help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zatelli, M. C.
Right arrow Articles by degli Uberti, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zatelli, M. C.
Right arrow Articles by degli Uberti, E. C.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 2 847-852
Copyright © 2000 by The Endocrine Society


Original Studies

Androgen Influences Transforming Growth Factor-ß1 Gene Expression in Human Adrenocortical Cells1

Maria C. Zatelli, Roberta Rossi and Ettore C. degli Uberti

Department of Biomedical Sciences and Advanced Therapies, Section of Endocrinology, University of Ferrara, 44100 Ferrara, Italy

Address all correspondence and requests for reprints to: Ettore C. degli Uberti, M.D., Department of Biomedical Sciences and Advanced Therapies, Section of Endocrinology, University of Ferrara, Via Savonarola 9, 44100 Ferrara, Italy. E-mail: ti8{at}dns.unife.it

Sex steroid hormones have been shown to affect adrenocortical function and trophism, yet little is known about androgen action in human adrenocortical gland. In this study we examined the effects of androgens on transforming growth factor-ß1 (TGFß1) production by the human adrenocortical cell line, NCI-H295, which we recently demonstrated to express androgen receptor and whose growth is significantly reduced by dihydrotestosterone (DHT) treatment.

TGFß1 is an important regulator of human adrenal development, with marked effects on steroid-producing cell function, and the production of distinct TGFß subtypes has been suggested to be regulated by steroid hormones in several tissues. To address potential TGFß1 induction by DHT, quantitative PCR and enzyme-linked immunoadsorbent assay were performed in NCI-H295 cells treated with DHT (from 10-12–10-9 mol/L). DHT led to a significant dose-dependent increase in TGFß1 messenger ribonucleic acid expression and in biologically active TGFß1 protein levels in the conditioned media of NCI-H295 cells, demonstrating that androgen can induce TGFß1 expression and production. TGFß1 (10-7–10-6 mol/L) was capable of significantly reducing cell proliferation (P < 0.05) after 24 h of treatment, as assessed by measuring [3H]thymidine incorporation in NCI-H295 cells. The addition of TGFß1-neutralizing antibody to cell cultures treated with different DHT concentrations (10-9 and 10-10 mol/L) blocked the inhibitory effect of TGFß1 on adrenocortical cell proliferation.

These findings suggest that TGFß1 exerts an inhibitory action on adrenocortical cell proliferation. Therefore, it might be reasonable to suppose that DHT could also influence human adrenocortical cell growth by involving TGFß1.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. S. Kirschner
Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. P. Ng, B. Hinz, and M. A. Swartz
Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro
J. Cell Sci., October 15, 2005; 118(20): 4731 - 4739.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Zatelli, A. Luchin, D. Piccin, F. Tagliati, A. Bottoni, C. Vignali, M. Bondanelli, and E. C. degli Uberti
Cyclooxygenase-2 Inhibitors Reverse Chemoresistance Phenotype in Medullary Thyroid Carcinoma by a Permeability Glycoprotein-Mediated Mechanism
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5754 - 5760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lafont, M. Laurent, H. Thibout, F. Lallemand, Y. Le Bouc, A. Atfi, and C. Martinerie
The Expression of novH in Adrenocortical Cells Is Down-regulated by TGFbeta 1 through c-Jun in a Smad-independent Manner
J. Biol. Chem., October 18, 2002; 277(43): 41220 - 41229.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Zatelli, F. Tagliati, J. E. Taylor, R. Rossi, M. D. Culler, and E. C. degli Uberti
Somatostatin Receptor Subtypes 2 and 5 Differentially Affect Proliferation in Vitro of the Human Medullary Thyroid Carcinoma Cell Line TT
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2161 - 2169.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. E. Chipuk, S. C. Cornelius, N. J. Pultz, J. S. Jorgensen, M. J. Bonham, S.-J. Kim, and D. Danielpour
The Androgen Receptor Represses Transforming Growth Factor-beta Signaling through Interaction with Smad3
J. Biol. Chem., January 4, 2002; 277(2): 1240 - 1248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society